IRadimed Corporation

IRadimed Corporation

IRMDยทNASDAQ

$91.12

+1.4%
HealthcareMedical - Devices

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.

At a Glance

Live Snapshot
Market Cap$1.16B
EPS1.7700
P/E Ratio51.48
Earnings Date07/30/2026
21.02%
Return on Invested Capital
9%
3Y+31.0%
5Y+732.0%
10Y-2.0%
23.76%
Return on Equity
7%
3Y+36.0%
5Y+965.0%
10Y+5.0%
20.67%
Return on Assets
6%
3Y+38.0%
5Y+973.0%
10Y+7.0%
IRadimed Corporation

IRadimed Corporation Management Team

IRMD ยท NASDAQ
MJ

Mr. Jeff Chiprin

Chief Commercial Officer

Compensation

$105,432

Born 1966(Age 60)
male
MJ

Mr. John F. Glenn

Chief Financial Officer & Corporate Secretary

Compensation

$574,820

Born 1962(Age 64)
male
MM

Mr. Matt Garner

Controller

male
MC

Mr. Chris Williamson

Executive Vice President of Continuous Improvement & Information Technology

male
MR

Mr. Roger E. Susi

Founder, Chairman, Chief Executive Officer & President

Compensation

$689,580

Born 1953(Age 73)
male
ML

Mr. Lynn Neuhardt

Vice President of Research & Development

Compensation

$354,946

male
MR

Mr. Randy Waddell

Vice President of Worldwide Sales & Marketing

Compensation

$446,151

male
irmd

IRadimed Corporation Insider Positioning

IRMD ยท NASDAQ

During the last 12 months, insiders have sold $9.52M worth of IRMD shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

43.2K

4.11M

Net Activity

-4.1M

-$4.11M

3-6 Months

Bought

0

0.00

Sold

48.3K

4.71M

Net Activity

-4.7M

-$4.71M

6-9 Months

Bought

0

0.00

Sold

8.1K

702.27K

Net Activity

-702K

-$702K

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

No buying activity

Top Sellers

1
SRE

Susi Roger E.

Director, 10 Percent Owner, Officer: Ceo, President, Chairman

81.2K sharesโ€ข28 transactions

$7.72M

2
GJ

Glenn John

Officer: Chief Financial Officer

14.5K sharesโ€ข1 transactions

$1.41M

3
HJB

Hawkins James B

Director

3.0K sharesโ€ข1 transactions

$290K

4
AMK

Allen Monty K

Director

1.0K sharesโ€ข1 transactions

$100K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $9.52M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$4.11M

Heavy recent selling activity. Recent insider sales notably exceed purchasesโ€”may warrant investigation into company developments.

Insider Participation

High Selling

4 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

Insider Activity Insight

Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.

SEC Filings

IRMD - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2026

N/A

April 30, 2026
June 23, 2026
2026
DEF 14A

DEF 14A 2025

N/A

April 30, 2025
June 19, 2025
2025
DEF 14A

DEF 14A 2024

N/A

April 29, 2024
June 20, 2024
2024
DEF 14A

DEF 14A 2023

N/A

April 28, 2023
June 15, 2023
2023
DEF 14A

DEF 14A 2022

N/A

April 27, 2022
June 10, 2022
2022
DEF 14A

DEF 14A 2021

N/A

April 28, 2021
June 11, 2021
2021
DEF 14A

DEF 14A 2020

N/A

April 29, 2020
June 12, 2020
2020
DEF 14A

DEF 14A 2019

N/A

April 30, 2019
June 14, 2019
2019
DEF 14A

DEF 14A 2018

N/A

April 27, 2018
June 08, 2018
2018
DEF 14A

DEF 14A 2017

N/A

April 28, 2017
June 09, 2017
2017
Showing 1 to 10 of 11 filings